Survival in Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis - Correlation of Clinical Phenotype with Histomorphological DiagnosisGeorg Jeryczynski, Heinz Gisslinger, Albert Woelfler et al.|Blood|2016Cited by 0
ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment OptionsJean‐Jacques Kiladjian, Christoph Klade, Francisca Ferrer‐Marín et al.|Blood|2024Cited by 0
Final results from a prospective, multicenter, non-interventional study (BESREMi-PASS) on the safety of ropeginterferon alfa-2b in 229 patients with polycythemia veraVeronika Buxhofer‐Ausch, Steffen Koschmieder, Krauth Maria-Theresa et al.|Blood|2025Cited by 0